AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVEX THERAPEUTICS LTD

0.110

0.000

Volume:- -

Turnover:- -

Market Cap:8.27M

PE:-6.11

High:0.110

Open:0.110

Low:0.110

Close:0.110

52wk High:0.150

52wk Low:0.090

Shares:75.15M

Float Shares:46.42M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.018

EPS(LYR):-0.018

ROE:-29.54%

ROA:-19.64%

PB:2.11

PE(LYR):-6.11

Loading ...

Overview Company News Filings

Company Profile

Company Name:

INVEX THERAPEUTICS LTD

Exchange:

ASX

Establishment Date:

2019

Employees:

- -

Office Location:

101 St Georges Terrace,Level 3,Perth,Western Australia,Australia

Website:

http://www.invextherapeutics.com

Zip Code:

6000

Phone:

Fax:

- -

Introduction:

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury. The company was incorporated in 2019 and is based in Subiaco, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/IXC.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IXC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IXC.AU\",,,,,undefined,":{"symbol":"IXC.AU","market":"AU","secType":"STK","nameCN":"INVEX THERAPEUTICS LTD","latestPrice":0.11,"timestamp":1790921520000,"preClose":0.11,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"INVEX THERAPEUTICS LTD","floatShares":46419706,"shares":75153848,"eps":-0.018,"marketStatus":"Market Closed","change":0,"latestTime":"10-02 16:12:00 AEST","open":0.11,"high":0.11,"low":0.11,"amount":0,"amplitude":0,"askPrice":0.11,"askSize":6424,"bidPrice":0.105,"bidSize":146681,"shortable":3,"etf":0,"ttmEps":-0.018,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791154800000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.11,"openAndCloseTimeList":[[1790899200000,1790920800000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IXC.AU","preClose":0.13,"auctionPrice":0.13,"auctionVolume":753,"auction":3,"marketStatus":"盘后竞价","timestamp":1787896800825}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IXC.AU\",,,,,undefined,":{"symbol":"IXC.AU","floatShares":46419706,"roa":"-19.64%","roe":"-29.54%","lyrEps":-0.018,"shares":75153848,"dividePrice":0,"high":0.11,"amplitude":0,"preClose":0.11,"low":0.11,"week52Low":0.09,"pbRate":"2.11","psRate":"176.55","week52High":0.15,"institutionHeld":0,"latestPrice":0.11,"committee":0.916084,"eps":-0.018,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.018,"open":0.11,"prevYearClose":0.12,"prevWeekClose":0.11,"prevMonthClose":0.11,"prevQuarterClose":0.11,"fiveDayClose":0.11,"twentyDayClose":0.105,"sixtyDayClose":0.105,"dividendGrowthYears":0,"fiveYearAvgDividendRate":3.105},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IXC.AU\",params:#limit:5,,,undefined,":[{"date":"2023-12-08","symbol":"IXC.AU","amount":0.1863,"announcedDate":"2023-11-30","type":"dividend","market":"AU","newRecordDate":"2023-12-11","defaultRemindTime":1701990000000,"name":"Invex Therapeutics","recordDate":"2023-12-18","payableDate":"2023-12-11","currency":"AUD","dateTimestamp":1701954000000,"payDate":"2023-12-18"},{"date":"2023-04-20","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1681948800000,"name":null,"time":"","dateTimestamp":1681912800000,"actualEps":null},{"date":"2023-01-25","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1674601200000,"name":null,"time":"","dateTimestamp":1674565200000,"actualEps":null},{"date":"2022-10-27","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1666825200000,"name":null,"time":"","dateTimestamp":1666789200000,"actualEps":null},{"date":"2022-07-06","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1657065600000,"name":null,"time":"","dateTimestamp":1657029600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IXC.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-12-08","recordDate":"2023-12-11","paymentDate":"2023-12-18","value":0.1863,"currency":"AUD"}],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":614309842,"yearFounded":2019,"address":"101 St Georges Terrace,Level 3,Perth,Western Australia,Australia","zipCode":"6000","officePhone":"61 8 6558 0886","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://www.invextherapeutics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.1579},{"period":"6month","weight":0.1},{"period":"1year","weight":-0.2667},{"period":"ytd","weight":-0.0833}],"compareEarnings":[{"period":"1week","weight":-0.0139},{"period":"1month","weight":-0.021},{"period":"3month","weight":-0.0216},{"period":"6month","weight":0.0239},{"period":"1year","weight":0.0634},{"period":"ytd","weight":0.0227}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury. The company was incorporated in 2019 and is based in Subiaco, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.042193},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.069596},{"month":3,"riseRate":0.714286,"avgChangeRate":0.169454},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.035683},{"month":5,"riseRate":0,"avgChangeRate":-0.171629},{"month":6,"riseRate":0.428571,"avgChangeRate":0.006764},{"month":7,"riseRate":0.625,"avgChangeRate":0.062637},{"month":8,"riseRate":0.625,"avgChangeRate":0.073821},{"month":9,"riseRate":0.125,"avgChangeRate":-0.065595},{"month":10,"riseRate":0.428571,"avgChangeRate":0.041219},{"month":11,"riseRate":0.571429,"avgChangeRate":0.067784},{"month":12,"riseRate":0.857143,"avgChangeRate":0.057464}],"exchange":"ASX","name":"INVEX THERAPEUTICS LTD","nameEN":"INVEX THERAPEUTICS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IXC.AU\",market:\"AU\",,,undefined,":null}}